Pharmacokinetics of intravitreal bevacizumab (Avastin).

By S. Bakri, M. Snyder, J. Reid, J. Pulido, Ravinder J Singh. Ophthalmology (Rochester, Minn.), 2007

704 citations recorded by the source corpus.

Subfields: Ophthalmology, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/98ceb867417d3989b85b5e6cfd17cd03ac85cb2e

Citations in the corpus

• Pharmacokinetic aspects of retinal drug delivery. (2017, neutral): “…has also been used as an argument for posterior elimination of bevacizumab, but this study is an outlier; three other rabbit and human studies indicate an anterior elimination (Bakri et al., 2007; Krohne et al., 2008; Meyer et al., 2011) (for detailed data analyses, see del Amo and Urtti (2015)).”